CHASE RANDAL D 4

What Happened

• Randal D. Chase, a director of GeoVax Labs, received an award/other acquisition of 6,000 shares on 2026-06-17. The shares are reported at $0.00 per share (transaction code A), indicating a grant or compensation award (derivative security) rather than a purchase. No cash value was exchanged in this transaction as reported.

Key Details

• Transaction date: 2026-06-17; Form 4 filed: 2026-06-22 (filed 5 days after the transaction).
• Transaction type/code: Award/Grant (A); reported as a derivative acquisition (Deriv.).
• Price: $0.00 per share; total reported cash value $0.
• Shares acquired: 6,000.
• Shares owned following transaction: not specified in the provided filing.
• Footnotes/plan info: none disclosed (no 10b5-1, no tax-withholding note reported).
• Timeliness: filing appears late (filed 2026-06-22 for a 2026-06-17 transaction).

Context

• A $0.00 per-share entry generally means this was a compensation grant (e.g., restricted stock or RSUs) rather than an open-market purchase; such awards may be subject to vesting or transfer restrictions and don’t necessarily signal buying/selling intent. The late filing should be noted by investors but does not by itself indicate anything about company fundamentals.